Strengthening Health Systems Together: Novartis Becomes an SCBF Member

SCBF is pleased to welcome Novartis as its new member.
Novartis has built the industry’s largest pipeline of treatments for malaria and neglected tropical diseases, backed by more than USD 500 million in investment in global health R&D since 2021, and recently announced a significant expansion of its community health programs around the world to close gaps in care for chronic diseases.
As part of these efforts, Novartis plans to expand initiatives to speed up diagnosis and treatment for heart disease and cancer in at least 10 low- and middle-income countries by 2030.

As a new member, Novartis will engage with SCBF’s network to exchange insights and contribute its experience in developing and implementing health system strengthening efforts at scale.
Picture Courtesy: Novartis Community Health Initiative launch events in Oaxaca, Mexico, Novartis







.png)

.png)











































.png)










.png)








































